Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 28, 2020; 26(44): 6929-6944
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.6929
Published online Nov 28, 2020. doi: 10.3748/wjg.v26.i44.6929
Table 3 Three-long noncoding RNA model and clinicopathologic parameters
Characteristic | Model | |||
High risk (%) | Low risk (%) | P value | χ2 | |
Age, median, yr | 0.11 | 0.74 | ||
≥ 60 | 52 (48.6) | 55 (51.4) | ||
< 60 | 43 (46.2) | 50 (53.8) | ||
Gender | 0.27 | 1.23 | ||
Male | 71 (50.0) | 71 (50.0) | ||
Female | 24 (41.4) | 34 (58.6) | ||
Bormann type | 0.00 | 14.29 | ||
I | 2 (13.3) | 13 (86.7) | ||
II | 36 (40.9) | 52 (59.1) | ||
III | 56 (59.6) | 38 (40.4) | ||
IV | 1 (33.3) | 2 (66.7) | ||
Tumor size | 0.06 | 3.64 | ||
≥ 5 cm | 48 (55.2) | 39 (44.8) | ||
< 5 cm | 47 (41.6) | 66 (58.4) | ||
Location | 0.77 | 0.52 | ||
Upper | 23 (52.3) | 21 (47.7) | ||
Middle | 26 (46.4) | 30 (53.6) | ||
Low | 46 (46.0) | 54 (54.0) | ||
Lauren type | 0.82 | 0.39 | ||
Intestinal | 45 (47.4) | 50 (52.6) | ||
Mixed | 23 (51.1) | 22 (48.9) | ||
Diffuse | 27 (45.0) | 33 (55.0) | ||
Tumor differentiation | 0.20 | 1.72 | ||
Moderate and well | 27 (40.9) | 39 (59.1) | ||
Poor | 68 (50.7) | 66 (49.3) | ||
Vessel invasion | 0.54 | 0.38 | ||
Yes | 30 (50.8) | 29 (49.2) | ||
No | 65 (46.1) | 76 (53.9) | ||
Perineural invasion | 0.06 | 3.52 | ||
Yes | 30 (58.8) | 21 (41.2) | ||
No | 65 (43.6) | 84 (56.4) | ||
TNM stage | 0.01 | 10.85 | ||
I | 13 (31.0) | 29 (69.0) | ||
II | 18 (38.3) | 29 (61.7) | ||
III | 63 (57.8) | 46 (42.2) | ||
IV | 1 (50.0) | 1 (50.0) |
- Citation: Zhang J, Piao HY, Wang Y, Lou MY, Guo S, Zhao Y. Development and validation of a three-long noncoding RNA signature for predicting prognosis of patients with gastric cancer. World J Gastroenterol 2020; 26(44): 6929-6944
- URL: https://www.wjgnet.com/1007-9327/full/v26/i44/6929.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i44.6929